Inflamm-aging and proteolytic cascades;Inflamm-âge et cascades protéolytiques

Medecine et Longevite

Volumn 1, Issue 1, 2009, Pages 38-43

  Hornebeck, W ^a  

^a CNRS   (France)

Author keywords

Inflamm Aging; Matrix metalloproteinases; Reactive oxygen species

Indexed keywords

MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE;

AGING; COLLAGEN DEGRADATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; INFLAMMATION; PROTEIN EXPRESSION; SHORT SURVEY;

EID: 72049094392     PISSN: 18757170     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mlong.2009.06.006     Document Type: Short Survey

References (35)

1. Carnes B.A., Staats D.O., and Sonntag W.E. Does senescence give rise to disease. Mech Ageing Dev 129 (2008) 693-699
2. Flint Beal M. Less stress, longer life. Nat Med 11 (2005) 598-599
3. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of aging. Nature 408 (2000) 239-247
4. Nelson K.K., and Melendez J.A. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 37 (2004) 768-784
5. Montagne W., and Carlisle K. Structural changes in aging human skin. J Invest Dermatol 73 (1979) 47-53
6. Lawker R.M., Zheng P., and Dong G. Aged skin: a study by light, transmission electron and scanning electron microscopy. J Invest Dermatol 88 (1987) 445-515
7. Fligiel S.E.G., Varani J., Datta S.H., Kang S., Fisher G.J., and Voorhees J.J. Collagen degradation in aged/photo aged skin in vivo and after exposure to MMP-1, in vitro. J Invest Dermatol 120 (2003) 842-848
8. Antonicelli A., Bellon G., Debelle L., and Hornebeck W. Elastin-Elastases and Inflamm-Aging. Current Top Dev Biol 79 (2007) 99-155
9. Matrisian L.M. Metalloproteinases and their inhibitors in Matrix remodelling. Trends Genet 6 (1990) 121-125
10. Visse R., and Nagase H. Matrix Metalloproteinases and tissue inhibitors of Metalloproteinases: structure, function and biochemistry. Circ Res 92 (2003) 827-839
11. Roy R., Zhang B., and Moses M.A. Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res 312 (2006) 608-622
12. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37 (1965) 614-636
13. Bizot-Foulon V., Bouchard B., Hornebeck W., Dubertret L., and Bertaux B. Uncoordinate expressions of type 1 and 3 collagens, collagenase and tissue inhibitor of matrix metalloproteinase 1 along in vitro proliferative life span of human skin fibroblasts. Regulation by all-trans retinoic acid. Cell Biol Int 19 (1995) 129-135
14. Varani K., Dame M.K., Rittie L., Fligiel S.E.G., Kang S., Fisher G.J., et al. Decreased Collagen Production in chronologically aged skin. Am J Pathol 168 (2006) 1861-1868
15. Kheradmand F., Werner E., Tremble P., Symons M., and Werb Z. Role of Rac-1 and Oxygen Radicals in Collagenase-1 expression induced by cell shape change. Science 280 (1998) 898-902
16. Nelson K.K., Subbaram S., Connor K.M., Daskupta J., Ha X.F., et al. Redox dependent Matrix Metalloproteinase-1 Expression is regulated by JNK through Ets and AP-1 promoter motifs. J Biol Chem 281 (2006) 14100-14110
17. Fischer G.J., Quan T., Purohit T., Shao Y., Cho M.K., He T., et al. Collagen fragmentation promotes oxidative stress and elevates Matrix Metalloproteinase-1 in fibroblasts in Aged skin. Am J Pathol 174 (2009) 101-114
18. Mine S., Fortunel N.O., Pageon H., and Asselineau D. Aging alters fonctionally human dermal papillary fibroblasts but not reticular fibroblasts: a new view of skin morphogenesis and aging. Plos/one 3 (2008) c4066
19. Kumar S., Millis A.J.T., and Baglioni C. Expression of Interleukin-1 inducible genes and production of interleukin 1 by aging human fibroblasts. Proc Natl Acad Sci U S A 89 (1992) 4683-4687
20. Shelton D.N., Chang E., Whittier P.S., Choi D., and Funk W.D. Microarray analysis of replicative senescence. Curr Biol 9 (1999) 1101-1110
21. Adair Kirk T.L., and Senior R.M. Fragments of extracellular matrix as mediators of Inflammation. Int J Biochem Cell Biol 40 (2008) 1101-1110
22. Hornebeck W., and Maquart F.X. Proteolyzed matrix as a template for the regulation of tumor progression. Biomed Pharmacother 57 (2003) 223-230
23. Weathington N.M., Van Houwelingen A.H., Noerager B.D., Jackson P.L., Kranevold A.D., Galin F.S., et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 12 (2006) 317-323
24. Daamen W.F., Nillesen S.T., Wismans R.G., Reinhardt D.P., Hafmans T., Veerkamp J.H., et al. A Biomaterial composed of Collagen and solubilised Elastin enhances Angiogenesis and Elastic fiber formation without calcification. Tissue Eng Part A 14 (2008) 349-360
25. Berton A., Rigot V., Huet E., Decarme M., Eeckhout Y., Patthy L., et al. Involvement of fibronectin type 2 repeats in the efficient inhibition of Gelatinases A and B by long-chain unsaturated fatty acids. J Biol Chem 276 (2001) 20458-20465
26. Huet E., Cauchard J.H., Berton A., Robinet A., Decarme M., Hornebeck W., et al. Inhibition of plasmin-mediated prostromelysin-1 activation by interaction of long-chain unsaturated fatty acids with kringle 5. Biochem Pharmacol 67 (2004) 643-654 [Erratum in: Biochem Pharmacol 2004;67:1011]
27. Manzano V.M., Puyol M.R., Puyol D.R., and Cazana F.J. Tretinoin prevents age - related renal changes and stimulates antioxidant defenses in cultured renal mesangial cells. J Pharmacol Exp Ther 289 (1999) 123-132
28. Fisher G.J., Datta S.C., Talwar M.S., Wang Z.Q., Varani J., Kang S., et al. Molecular basis of sun - induced premature skin ageing and retinoid antagonism. Nature 379 (1998) 335-339
29. Harikumar K.B., and Aggarwal B.B. Resveratrol: a multitargeted agent for age - associated chronic diseases. Cell cycle 7 (2008) 1020-1035
30. Zhu Y.Z., Huang S.H., Tan B.K.H., Sun J., Whiteman M., and Zhu Y.C. Anti-oxydants in chinese herbal medicines: a biochemical perspective. Nat Prod Rep 21 (2004) 478-489
31. Tixier J.M., Godeau G., Robert A.M., and Hornebeck W. Evidence by in vivo and in vitro studies that binding of pycnogenols to elastin affects its rate of degradation by elastases. Biochem Pharmacol 33 (1984) 3933-3939
32. Sartor L., Pezzato E., and Garbisa S. (-) Epigallo catechin-3- gallate inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema and invasion. J leukoc Biol 71 (2002) 73-79
33. Corps A.N., Curry V.A., Buttle D.J., Hazleman B.L., and Riley G.P. Inhibition of interleukin -1 beta - stimulated collagenase and stromelysin expression in human tendon fibroblasts by epigallocatechin galate ester. Matrix Biol 23 (2004) 163-169
34. Yamakawa S., Asai T., Uchida T., Matsukawa M., Akizawa T., and Oku N. (-) Epigallocatechin gallate inhibits membrane - type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer lett 210 (2004) 47-55
35. Lee J.H., Chung J.H., and Cho K.H. The effects of epigallocatechin-3- gallate on extracellular matrix metabolism. J Dermatol Sci 40 (2005) 195-204